Birchview Capital, LP
- SEC CIK
- 0001618205
- Latest filing
- Aug 14, 2026
Holdings in Q4 2021
Holdings as of Dec 31, 2021, filed Feb 14, 2022. Long positions only; changes compare share counts with Q3 2021.
- Positions
- 67
- +3 vs. Q3 2021
- Portfolio value
- $155.1M
- +$8.11M (+5.5%) vs. Q3 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| BMYBristol Myers Squibb Co | Stock | 766,106 | $47.8M | 30.8% | −30,000−3.8% | Reduced | History |
| AXDXAccelerate Diagnostics, Inc | COM | 2,252,388 | $11.7M | 7.6% | 00.0% | Unchanged | History |
| ELUTElutia Inc. | CL A COM | 1,417,923 | $8.35M | 5.4% | +1,367,923+2,735.8% | Added | History |
| QDELQuidelOrtho Corp | COM | 59,684 | $8.06M | 5.2% | 00.0% | Unchanged | History |
| NBIXNeurocrine Biosciences Inc | Stock | 89,200 | $7.60M | 4.9% | +9,000+11.2% | Added | History |
| FHTXFoghorn Therapeutics Inc. | COM | 314,143 | $7.18M | 4.6% | 00.0% | Unchanged | History |
| BDSXBiodesix Inc | COM | 1,252,753 | $6.63M | 4.3% | +147,800+13.4% | Added | History |
| ACADAcadia Pharmaceuticals Inc | COM | 199,400 | $4.65M | 3.0% | 00.0% | Unchanged | History |
| UTHRUnited Therapeutics Corp | COM | 18,000 | $3.89M | 2.5% | 00.0% | Unchanged | History |
| BIIBBiogen Inc. | COM | 12,600 | $3.02M | 1.9% | 00.0% | Unchanged | History |
| ALBOAlbireo Pharma, Inc. | COM | 113,000 | $2.63M | 1.7% | 00.0% | Unchanged | History |
| MASIMasimo Corp | COM | 8,000 | $2.34M | 1.5% | 00.0% | Unchanged | History |
| ARNAArena Pharmaceuticals Inc | COM NEW | 22,000 | $2.04M | 1.3% | 00.0% | Unchanged | History |
| PRTAProthena Corp Public Ltd Co | SHS | 40,247 | $1.99M | 1.3% | 00.0% | Unchanged | History |
| INBXInhibrx Biosciences, Inc. | COM | 40,000 | $1.75M | 1.1% | +40,000 | New | History |
| CLRContinental Resources, Inc | COM | 38,600 | $1.73M | 1.1% | 00.0% | Unchanged | History |
| BHVNBiohaven Ltd. | COM | 12,000 | $1.65M | 1.1% | +2,000+20.0% | Added | History |
| KPTIKaryopharm Therapeutics Inc. | COM | 246,000 | $1.58M | 1.0% | 00.0% | Unchanged | History |
| HROWHarrow, Inc. | COM | 180,000 | $1.55M | 1.0% | 00.0% | Unchanged | History |
| IMGNImmunoGen, Inc. | COM | 190,000 | $1.41M | 0.9% | 00.0% | Unchanged | History |
| ETRNMidstream Co LLC | COM | 133,050 | $1.38M | 0.9% | 00.0% | Unchanged | History |
| NKTRNektar Therapeutics | COM | 100,000 | $1.35M | 0.9% | +28,000+38.9% | Added | History |
| PTGXProtagonist Therapeutics, Inc | COM | 38,000 | $1.30M | 0.8% | 00.0% | Unchanged | History |
| ARVNArvinas, Inc. | COM | 15,000 | $1.23M | 0.8% | 00.0% | Unchanged | History |
| ALKSAlkermes plc. | SHS | 50,000 | $1.16M | 0.7% | 00.0% | Unchanged | History |
| OVVOvintiv Inc. | COM | 34,200 | $1.15M | 0.7% | 00.0% | Unchanged | History |
| CYTKCytokinetics Inc | COM NEW | 25,000 | $1.14M | 0.7% | 00.0% | Unchanged | History |
| GOSSGossamer Bio, Inc. | COM | 100,000 | $1.13M | 0.7% | +60,000+150.0% | Added | History |
| AMRNAmarin Corp PLC | SPONS ADR NEW | 300,000 | $1.01M | 0.7% | 00.0% | Unchanged | History |
| CORTCorcept Therapeutics Inc | COM | 50,000 | $990.0K | 0.6% | 00.0% | Unchanged | History |
| VNDAVanda Pharmaceuticals Inc. | COM | 60,000 | $941.0K | 0.6% | −20,000−25.0% | Reduced | History |
| BLUEbluebird bio, Inc. | COM | 84,000 | $839.0K | 0.5% | 00.0% | Unchanged | History |
| PGNYProgyny, Inc. | COM | 15,000 | $755.0K | 0.5% | 00.0% | Unchanged | History |
| ChemoCentryx, Inc.16383L106 | COM | 20,000 | $728.0K | 0.5% | −5,000−20.0% | Reduced | – |
| TSVT2seventy bio, Inc. | COMMON STOCK | 27,999 | $718.0K | 0.5% | +27,999 | New | History |
| CGEMCullinan Therapeutics, Inc. | COM | 45,114 | $696.0K | 0.4% | 00.0% | Unchanged | History |
| PXDPioneer Natural Resources Co | COM | 3,800 | $691.0K | 0.4% | 00.0% | Unchanged | History |
| ZNTLZentalis Pharmaceuticals, Inc. | COM | 8,000 | $672.0K | 0.4% | 00.0% | Unchanged | History |
| AVEOAveo Pharmaceuticals, Inc. | COM NEW | 140,000 | $657.0K | 0.4% | +100,000+250.0% | Added | History |
| NARIInari Medical, Inc. | Stock | 7,000 | $639.0K | 0.4% | 00.0% | Unchanged | History |
| APLSApellis Pharmaceuticals, Inc. | COM | 12,000 | $567.0K | 0.4% | 00.0% | Unchanged | History |
| KALVKalVista Pharmaceuticals, Inc. | COM | 40,000 | $529.0K | 0.3% | 00.0% | Unchanged | History |
| CFRXCONTRAFECT Corp | COM | 200,000 | $526.0K | 0.3% | 00.0% | Unchanged | History |
| VTYXVentyx Biosciences, Inc. | COM | 25,000 | $497.0K | 0.3% | +25,000 | New | History |
| XNCRXencor Inc | COM | 12,300 | $493.0K | 0.3% | 00.0% | Unchanged | History |
| IRTCiRhythm Holdings, Inc. | COM | 4,000 | $471.0K | 0.3% | 00.0% | Unchanged | History |
| FOLDAmicus Therapeutics, Inc. | COM | 38,000 | $439.0K | 0.3% | 00.0% | Unchanged | History |
| GTHXG1 Therapeutics, Inc. | COM | 40,000 | $408.0K | 0.3% | 00.0% | Unchanged | History |
| TPTXTurning Point Therapeutics, Inc. | COM | 8,000 | $382.0K | 0.2% | 00.0% | Unchanged | History |
| STOKStoke Therapeutics, Inc. | COM | 15,000 | $360.0K | 0.2% | 00.0% | Unchanged | History |
| SLNOSoleno Therapeutics Inc | COM | 876,899 | $360.0K | 0.2% | 00.0% | Unchanged | History |
| KNSAKiniksa Pharmaceuticals International, plc | COM CL A | 30,000 | $353.0K | 0.2% | 00.0% | Unchanged | History |
| SILKSilk Road Medical Inc | COM | 8,000 | $341.0K | 0.2% | +8,000 | New | History |
| IFRXInflaRx N.V. | COM | 70,000 | $333.0K | 0.2% | 00.0% | Unchanged | History |
| TGTXTG Therapeutics, Inc. | COM | 15,000 | $285.0K | 0.2% | 00.0% | Unchanged | History |
| BCRXBiocryst Pharmaceuticals Inc | COM | 20,000 | $277.0K | 0.2% | 00.0% | Unchanged | History |
| ISEEIVERIC bio, Inc. | COM | 15,000 | $251.0K | 0.2% | 00.0% | Unchanged | History |
| PFEPfizer Inc | Stock | 4,000 | $236.0K | 0.2% | +4,000 | New | History |
| LSFLaird Superfood, Inc. | COM STK | 18,000 | $235.0K | 0.2% | +4,000+28.6% | Added | History |
| AKBAAkebia Therapeutics, Inc. | COM | 100,000 | $226.0K | 0.1% | 00.0% | Unchanged | History |
| AWHLAspira Women's Health Inc. | COM | 103,104 | $182.0K | 0.1% | 00.0% | Unchanged | History |
| ELTXElicio Therapeutics, Inc. | COM | 54,392 | $158.0K | 0.1% | 00.0% | Unchanged | History |
| SIENProject Sage Oldco, Inc. | COM | 40,000 | $147.0K | 0.1% | 00.0% | Unchanged | History |
| DCGODocGo Inc. | COM | 10,000 | $94.0K | 0.1% | +10,000 | New | History |
| YTENYIELD10 Bioscience, Inc. | COM | 18,750 | $92.0K | 0.1% | −35−0.2% | Reduced | History |
| CNCEConcert Pharmaceuticals, Inc. | COM | 20,000 | $63.0K | <0.1% | 00.0% | Unchanged | History |
| TXMDTherapeuticsMD, Inc. | COM | 50,000 | $18.0K | <0.1% | −50,000−50.0% | Reduced | History |
Sold out since Q3 2021 (3)
Positions held at the end of Q3 2021 that are gone from this filing.
| Security | Class | Shares in Q3 2021 | Value in Q3 2021 | % of portfolio in Q3 2021 | History |
|---|---|---|---|---|---|
| XLRNAcceleron Pharma Inc | COM | 10,672 | $1.84M | 1.3% | History |
| BIORBiora Therapeutics, Inc. | COM | 270,000 | $410.0K | 0.3% | History |
| ARQTArcutis Biotherapeutics, Inc. | COM | 9,000 | $215.0K | 0.1% | History |